Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

65 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q4 2024.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,759,114 shares of 43,411,663 outstanding shares and own 27.1% of the company stock.
Largest 10 shareholders include Bleichroeder LP (4,997,240 shares), VANGUARD GROUP INC (2,056,176 shares), BlackRock, Inc. (638,952 shares), GEODE CAPITAL MANAGEMENT, LLC (631,281 shares), Robertson Stephens Wealth Management, LLC (478,500 shares), Sigma Planning Corp (447,175 shares), Good Life Advisors, LLC (400,000 shares), BANK OF AMERICA CORP /DE/ (324,315 shares), ADVISORY RESEARCH INC (257,225 shares), and STIFEL FINANCIAL CORP (211,361 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.